Retractable Technologies (NYSE:RVP) Receives New Coverage from Analysts at StockNews.com

Research analysts at StockNews.com initiated coverage on shares of Retractable Technologies (NYSE:RVP) in a report released on Wednesday. The firm set a “hold” rating on the stock.

Retractable Technologies Stock Performance

RVP opened at $1.07 on Wednesday. The stock has a market cap of $32.03 million, a PE ratio of -4.46 and a beta of 2.11. The company has a current ratio of 8.28, a quick ratio of 6.41 and a debt-to-equity ratio of 0.01. Retractable Technologies has a 1 year low of $0.95 and a 1 year high of $1.90. The stock’s 50 day simple moving average is $1.21 and its 200-day simple moving average is $1.16.

Institutional Trading of Retractable Technologies

A number of institutional investors and hedge funds have recently modified their holdings of RVP. Bridgeway Capital Management LLC grew its position in Retractable Technologies by 20.1% in the fourth quarter. Bridgeway Capital Management LLC now owns 149,534 shares of the company’s stock valued at $166,000 after acquiring an additional 25,000 shares during the period. WealthTrust Axiom LLC grew its position in Retractable Technologies by 27.8% in the third quarter. WealthTrust Axiom LLC now owns 126,533 shares of the company’s stock valued at $151,000 after acquiring an additional 27,500 shares during the period. Renaissance Technologies LLC grew its position in Retractable Technologies by 21.1% in the second quarter. Renaissance Technologies LLC now owns 195,171 shares of the company’s stock valued at $224,000 after acquiring an additional 33,947 shares during the period. DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main grew its position in Retractable Technologies by 314.2% in the fourth quarter. DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main now owns 58,400 shares of the company’s stock valued at $96,000 after acquiring an additional 44,300 shares during the period. Finally, Jane Street Group LLC bought a new stake in Retractable Technologies in the fourth quarter valued at $27,000. 7.58% of the stock is currently owned by institutional investors.

About Retractable Technologies

Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.